Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Similar Videos
Shareholder proposal rule
Keith Higgins, chair of Ropes & Gray’s securities & governance practice, examines SEC Rule 14a-8, the shareholder proposal rule.
China’s new cybersecurity law
Mimi Yang, a Ropes & Gray government enforcement partner in Hong Kong, provides an overview of China’s new cybersecurity law (CSL), which came into effect in June 2017.
FTC's merger remedies study
Jonathan Klarfeld, Ropes & Gray antitrust partner, discusses key takeaways and likely impacts of the Federal Trade Commission's recent divestiture study.
Value-based health care: provider integration
John Chesley, Ropes & Gray health care partner, addresses developments for providers to consider as they integrate and move towards value-based health care models.
Department of Labor's Fiduciary Rule
David Tittsworth, Ropes & Gray investment management counsel, analyzes the possible fate of the Department of Labor’s Fiduciary Rule.
Changing values of IP and data in deals
Ed Black, co-head of Ropes & Gray’s IP transactions and technology, media & telecommunications practice groups, discusses changing values of IP and data in M&A transactions.